BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31744307)

  • 1. Bilateral Anterior and Intermediate Uveitis Associated With Omeprazole.
    Shifera AS
    Ann Pharmacother; 2020 Apr; 54(4):397-399. PubMed ID: 31744307
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical difluprednate monotherapy for uveitic macular edema.
    Symes RJ; Forooghian F
    Can J Ophthalmol; 2016 Feb; 51(1):47-9. PubMed ID: 26874159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole-induced cough in a patient with gastroesophageal reflux disease.
    Reiche I; Tröger U; Martens-Lobenhoffer J; Kandulski A; Neumann H; Malfertheiner P; Bode-Böger SM
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):880-2. PubMed ID: 19801940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quiz Page March 2016: A 60-Year-Old Man With Fever, Night Sweats, and Acute Kidney Injury.
    Tobin E; Pokharel S; Haqqie S; Asif A
    Am J Kidney Dis; 2016 Mar; 67(3):xxi-xxiii. PubMed ID: 26916377
    [No Abstract]   [Full Text] [Related]  

  • 5. [Using ursodez in the treatment of refractory form of gastroesophageal reflux disease].
    Osadchuk AM; Davydkin IL
    Eksp Klin Gastroenterol; 2012; (4):74-5. PubMed ID: 23402158
    [No Abstract]   [Full Text] [Related]  

  • 6. It is difficult to discontinue PPI treatment in patients with GERD.
    Bjornsson E
    Am J Gastroenterol; 2011 Feb; 106(2):367-8; author reply 368. PubMed ID: 21301460
    [No Abstract]   [Full Text] [Related]  

  • 7. Nutritional Optic Neuropathy From Chronic Omeprazole Use.
    Rehmani A; Mehta I; Siu NY; Smith E
    J Neuroophthalmol; 2021 Jun; 41(2):e169-e171. PubMed ID: 33999892
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].
    Lundell L
    Lakartidningen; 2009 Feb 18-24; 106(8):502-5. PubMed ID: 19350782
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
    Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
    Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial).
    Waghray A; Waghray N; Perzynski AT; Votruba M; Wolfe MM
    Dig Dis Sci; 2019 Jan; 64(1):158-166. PubMed ID: 30094626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.
    McColl KE; Gillen D
    Gastroenterology; 2009 Jul; 137(1):20-2. PubMed ID: 19482105
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.
    Waldum HL; Hauso Ø; Fossmark R
    Aliment Pharmacol Ther; 2015 Aug; 42(3):389. PubMed ID: 26147114
    [No Abstract]   [Full Text] [Related]  

  • 14. [The administration of proton-pump inhibitors in little children or patients with difficulties in deglutition].
    De Rocker H
    J Pharm Belg; 2009 Sep; (3):89-90. PubMed ID: 19873849
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
    Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
    Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
    J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
    MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of fundoplication for gastroesophageal reflux in the outcome of benign tracheal stenosis.
    Bianchi ET; Guerreiro Cardoso PF; Minamoto H; Bibas BJ; Salati M; Pego-Fernandes PM;
    J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1698-1706. PubMed ID: 31587887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
    Wang L; Zhou L; Lin S; Hu H; Xia J
    J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.